Stocktoria
ADMA BIOLOGICS, INC. ADMA
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2013-10-17
ADMA BIOLOGICS, INC. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 18,644,711 | $208.4M | 7.61% |
| D. E. Shaw & Co., Inc. | 5,274,597 | $44.1M | 2.15% |
| TWO SIGMA INVESTMENTS, LP | 2,019,887 | $16.9M | 0.82% |
| CITADEL ADVISORS LLC | 1,620,271 | $13.6M | 0.66% |
| AQR CAPITAL MANAGEMENT LLC | 1,525,581 | $12.8M | 0.62% |
| MILLENNIUM MANAGEMENT LLC | 1,154,228 | $9.7M | 0.47% |
| RENAISSANCE TECHNOLOGIES LLC | 652,530 | $5.5M | 0.27% |
| Point72 Asset Management, L.P. | 499,135 | $4.2M | 0.2% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.